| Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort |
21 |
| Successful Second-Line Metronomic Temozolomide in Metastatic Paraganglioma: Case Reports and Review of the Literature |
6 |
| Tumor Treating Fields for Glioblastoma Treatment: Patient Satisfaction and Compliance With the Second-Generation Optune (R) System |
5 |
| A Single Institution Experience of Incorporation of Cisplatin into Adjuvant Chemotherapy for Patients With Triple-Negative Breast Cancer of Unknown BRCA Mutation Status |
4 |
| The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer |
4 |
| Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review |
4 |
| Programmed Death-ligand 1 Expression With Clone 22C3 in Non-small Cell Lung Cancer: A Single Institution Experience |
3 |
| Methylation and Gene Expression of BCAT1 and IKZF1 in Colorectal Cancer Tissues |
3 |
| Precision Medicine in Head and Neck Cancer: Myth or Reality? |
3 |
| Access to Palliative Care for Cancer Patients Living in a Northern and Rural Environment in Ontario, Canada: The Effects of Geographic Region and Rurality on End-of-Life Care in a Population-Based Decedent Cancer Cohort |
3 |
| Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study |
3 |
| Correlation Between the Sites of Onset of Basal Cell Carcinoma and the Embryonic Fusion Planes in the Auricle |
2 |
| Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab |
2 |
| Follicular Dendritic Cell Sarcoma or Not? A Series of 5 Diagnostically Challenging Cases |
2 |
| Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy |
2 |
| PAK1 Expression in Pancreatic Cancer: Clinicopathological Characteristics and Prognostic Significance |
2 |
| A Surgical Case of Inflammatory Myofibroblastic Tumor of the Liver: Potentially Characteristic Gross Features |
1 |
| Major Stressful Life Events and Risk of Developing Lung Cancer: A Case-Control Study |
1 |
| Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer |
1 |
| Adenosquamous Carcinoma of the Pancreas |
1 |
| Investigation of Complications Following Port Insertion in a Cancer Patient Population: A Retrospective Analysis |
1 |
| Early Clinical Outcomes, Patterns of Failure, and Acute Haematologic Toxicity of Image-Guided Volumetric Modulated Arc Therapy (IG-VMAT) in the Definitive Treatment of Locally Advanced Carcinoma Cervix |
1 |
| The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy |
1 |
| Myoepithelial Cell Carcinoma of the Oral Tongue: Case Report and Review of the Literature |
1 |
| Malignant Peritoneal Mesothelioma in the setting of a Ventriculo-Peritoneal Shunt: A novel clinical presentation |
1 |
| Epidemiological Determinants of Advanced Prostate Cancer in Elderly Men in the United States |
0 |
| A Rare Primary Tumor of the Thyroid Gland: A New Case of Leiomyoma and Literature Review |
0 |
| Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience |
0 |
| Expression of Bone Morphogenetic Protein-7 Significantly Correlates With Non-small Cell Lung Cancer Progression and Prognosis: A Retrospective Cohort Study |
0 |
| Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach |
0 |
| A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach |
0 |
| Improvement of Chemotherapy Solutions Production Procedure in a Hospital Central Chemotherapy Preparation Unit: A Systematic Risk Assessment to Prevent Avoidable Harm in Cancer Patients |
0 |
| Identifying Risk Factors for Morbidity and Mortality in Patients with Primary Head and Neck Cancers in a Nigerian Population |
0 |
| Hepatotoxicities Induced by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases: Distinguishing the True From the False |
0 |
